The UMCG website shows YouTube videos. YouTube places cookies if you watch them. Choose ‘Rather not’ if you do not want these cookies. We also place cookies of our own. These help us improve the usability of our website.
BRIDGE develops medical imaging solutions to improve the effectiveness of treatments based on state-of-the-art technology, software analysis tools, and big data. The BRIDGE research activities cover all stages, from early development to clinical practice.
The BRIDGE research programme brings together clinical imaging experts, IT experts, imaging methodology experts, basic scientists, and clinicians. Together, we can see, understand, and treat:
Personalized medicine has become pivotal in diagnosis and treatment because it provides each patient with optimal treatment. Our advanced medical imaging solutions not only contribute to the improved treatment of oncological diseases but are also increasingly important to the disciplines of infection and inflammation, cardiology, and neurology.
The BRIDGE research programme uses medical imaging for prevention, early detection, staging, and therapy and, therefore, helps clinicians to tailor treatment to each individual patient. BRIDGE brings together all professionals working in this field, from basic scientists to methodological experts, translational experts, imaging specialists, and clinicians. Innovative biomarkers and techniques are being developed together with just one aim: helping our patients.
The translation and implementation of new imaging biomarkers requires the demonstration of their mechanism, the assessment of their performance and robustness, the determination of the optimal way of data collection, and the assessment of its clinical value. The BRIDGE research activities include:
The BRIDGE research activities allow the standardization, validation, calibration, and testing of measurement methods, to guarantee reproducibility and result robustness. The BRIDGE research activities include:
Imaging has become an integral part of the workup in patient care and therapy. Imaging is used for diagnosis, treatment prediction, selection and planning, response monitoring, and the assessment of tissue damage. This technique helps to identify patients who are more likely to benefit from complex treatments, therefore avoiding unnecessary or inappropriate treatments. The BRIDGE research activities include:
University Medical Center Groningen (UMCG)
W.J. Kolff Institute
Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE)
P.O. Box 196
9700 AD Groningen